How The Patient Rights Revolution Builds on America’s 1776 One
By MICHAEL MILLENSON It took 129 years for the inalienable rights proclaimed in America’s Declaration…
How The Patient Rights Revolution Builds on America’s 1776 One
By MICHAEL MILLENSON It took 129 years for the inalienable rights proclaimed in America’s Declaration of Independence to apply to the rights of patients in relationship to their doctors. In 1905, an Illinois appellate court ruled in favor of a woman who’d sued her surgeon for performing a hysterectomy without disclosing in advance what procedure…
New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in Breast Cancer
Gilead Sciences antibody drug conjugate Trodelvy is now approved as a first-line treatment for triple-negative breast cancer. This expanded approval for Trodelvy comes with a slightly broader label that gives it an edge over the AstraZeneca and Daiichi Sankyo ADC Datroway. The post New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in…
New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers. The post New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases appeared first on MedCity News.
Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News.
Protected: How Unaffordable is Health Care? A Short Video Series from KFF
There is no excerpt because this is a protected post.
Protected: Video: Health Care Affordability at the Macro Level
There is no excerpt because this is a protected post.
How Foreign Reference Pricing Embeds Valuations And Risks Undermining Global Innovation
That is the title of my new Health Affairs Forefront piece out today with Lou Garrison and Richard Xie. An excerpt from the article is below: United States policy makers increasingly argue that Americans pay too much for prescription drugs. In a recent report, the Senate Health, Education, Labor, and Pensions (HELP) Committee minority staff contended…
Keeping Up With Clinicians
AI adoption in healthcare isn’t being led by innovation teams, it’s the clinicians The post Keeping Up With Clinicians appeared first on MedCity News.
Women’s Health Is Not a Wearable Feature — It’s an Operating System Problem
The issue is not only functional. It is experiential. Many women do not need more scores. They need continuity, context, and support that feels companionable rather than corrective. The post Women’s Health Is Not a Wearable Feature — It’s an Operating System Problem appeared first on MedCity News.
Key Facts About Medicare Spending Trends and Projections from the 2026 Medicare Trustees Report
This brief provides an overview of key trends in Medicare spending and spending growth, as well as the impact of these trends on out-of-pocket costs for Medicare beneficiaries and Medicare program solvency, as projected by the Medicare Trustees in the 2026 Trustees Report.
